… Further, to exclude possible prevalent cervical cancers at the date of HPV vaccination, we
used a buffer period of 1 to 5 years at 1-year intervals after the index date of HPV vaccination (…

… HPV subunit vaccine protects women from a high proportion of precursor lesions of cervical
… examine the ramifications and remaining questions that surround preventive HPV vaccines. …

… of HPV vaccination against cervical cancer among young … , HPV vaccine effectiveness against
cervical cancer has been … our results for the women vaccinated before age 20 years agree …

… , oncogenic) HPV types occur … HPV infection and the risk of developing cervical cancer in
women over 25 years of age and whether they would also benefit from vaccination against HPV…

… 4 , but the incidences of these cancers and the fractions that are attributable to HPV
infection are lower, and so HPV vaccines have principally been used to target cervical cancer. …

… , for cervical cancer screening (2). In this article, I highlight the development of prophylactic
HPV vaccines, their ability to reduce HPV-… The initial HPV vaccine research was conducted in …

… HPV vaccination will protect against cervical cancer. Trials have not focused on the outcome
of cervical cancer … them up for long enough: cervical cancer may take decades to develop. …

… of HPV vaccines has taken many years, since there is no effective culture system to propagate
HPV. The … There are 15 HPV genotypes which have carcinogenic potential; so far, the …

… greater than the relative fall in cervical cancer following HPV vaccination. They suggest that
because the risk of CIN3 progressing to cervical cancer in an immunised individual is lower …

… endeavors in HPV vaccine development, we may soon be able to implement a variety of
safe and effective strategies for the eventual control of HPV-associated cervical cancer. …